Status:
NOT_YET_RECRUITING
Prevalence of Hemolytic Uremic Syndrome (HUS) in Pediatrics
Lead Sponsor:
Assiut University
Conditions:
Prevalence of Hemolytic Uremic Syndrome
Eligibility:
All Genders
1-18 years
Brief Summary
To determine the prevalence of hemolytic uremic syndrome (HUS) among pediatric patients admitted to Assiut University Children's Hospital, and to describe the demographic, clinical, and laboratory cha...
Detailed Description
Hemolytic uremic syndrome (HUS) is a rare but serious condition characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. \[1\] Two main subtypes of H...
Eligibility Criteria
Inclusion
- Patients aged below 18 years at the time of diagnosis.
- Confirmed diagnosis of HUS based on the clinical triad (microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury).
Exclusion
- Patients aged 18 years or above at the time of diagnosis.
- Incomplete or missing medical records that do not confirm the diagnosis.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07171749
Start Date
October 1 2025
End Date
October 30 2026
Last Update
September 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.